NEW YORK, Sept. 7 /PRNewswire/ — Reportlinker.com announces
that a new market research report is available in its
catalogue:
Hypertension: Competing Treatments and Market Entry
Considerations
http://www.reportlinker.com/p0287870/Hypertension-Competing-Treatments-and-Market-Entry-Considerations.html
This report presents the findings of a global survey on current
treatments and prescribing practices for Hypertension. These
findings were made following the participation of more than 280
clinics worldwide, which provided detailed information of their
treatment practices.
Today, approximately 1 billion people worldwide have high blood
pressure, a figure expected to increase to 1.5 billion by 2025,
affecting 1 in 3 adults over the age of 20 (Lancet.
2005;365:217-223). Hypertension is commonly seen in developing as
well as developed countries and, where it remains untreated,
presents a major risk factor for heart attack, stroke, kidney
failure and other cardiovascular diseases.
In a field where therapies are often unsatisfactory, physicians
seek to extent their understanding and use of available treatments
to improve patient outcomes. Knowledge in these areas is also
important to drug developers, who seek a better understanding of
prescribing practices and treatment needs and limitations from the
clinician’s perspective, as part of their own efforts to develop
more effective therapies. To meet interest in these areas, Biopharm
Reports has conducted a global survey on current treatments and
drug prescribing practices for Hypertension. This survey involved
the participation of more than 280 clinical centres in 50
countries. In a
‘/>”/>
SOURCE
